BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/2/2015 11:57:00 AM | Browse: 487 | Download: 568
Publication Name World Journal of Ophthalmology
Manuscript ID 15585
Country/Territory United States
2014-11-29 12:58
Peer-Review Started
2014-11-29 13:43
To Make the First Decision
2014-12-12 17:31
Return for Revision
2014-12-18 10:44
2015-01-12 12:17
Second Decision
2015-02-26 17:36
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-03-05 18:18
Articles in Press
2015-03-05 18:19
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-04-27 16:05
Publish the Manuscript Online
2015-05-19 17:29
ISSN 2218-6239 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Ophthalmology
Manuscript Type Minireviews
Article Title Current understanding and management of aggressive posterior retinopathy of prematurity
Manuscript Source Invited Manuscript
All Author List Christine M Pulido and Polly A Quiram
Funding Agency and Grant Number
Corresponding Author Polly A Quiram, MD, PhD, VitreoRetinal Surgery, P.A., 7760 France Ave S, Suite 310, Minneapolis, MN 55435, United States. pollyquiram@yahoo.com
Key Words Bevacizumab Eliminates the Angiogenic Threat of Retinopathy of Prematurity; Photographic Screening for Retinopathy of Prematurity; Aggressive posterior retinopathy of prematurity; Retinopathy of prematurity; Intravitreal bevacizumab; Early Treatment of Retinopathy of Prematurity Study; Stanford University Network for Diagnosis of Retinopathy of Prematurity
Core Tip Neonates with aggressive posterior retinopathy of prematurity often have unfavorable visual outcomes due to the aggressive and destructive nature of the disease. Treatment options, including laser and anti-vascular endothelial growth factor therapy can change the course of the disease, but both with potential side effects. Case studies and recommendations regarding the management of these complicated cases are reviewed.
Publish Date 2015-05-19 17:29
Citation Pulido CM, Quiram PA. Current understanding and management of aggressive posterior retinopathy of prematurity. World J Ophthalmol 2015; 5(2): 73-79
URL http://www.wjgnet.com/2218-6239/full/v5/i2/73.htm
DOI http://dx.doi.org/10.5318/wjo.v5.i2.73
Full Article (PDF) WJO-5-73.pdf
Full Article (Word) WJO-5-73.doc
Manuscript File 15585-Review.docx
Answering Reviewers 15585-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form 15585-Conflict-of-interest statement.pdf
Copyright License Agreement 15585-Copyright assignment.pdf
Peer-review Report 15585-Peer-review(s).pdf
Scientific Misconduct Check 15585-Scientific misconduct check.pdf
Scientific Editor Work List 15585-Scientific editor work list.pdf